![Atsushi Wakamiya](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Atsushi Wakamiya
Founder at EneCoat Technologies Co., Ltd.
Network origin in Atsushi Wakamiya first degree
Entity | Entity type | Industry | |
---|---|---|---|
EneCoat Technologies Co., Ltd.
![]() EneCoat Technologies Co., Ltd. SemiconductorsElectronic Technology EneCoat Technologies Co., Ltd. is a company based in Kyoto, Japan that focuses on developing materials for perovskite solar cells and manufacturing modules. The Japanese company aims to promote the effective use of natural energy and protect the environment to create a better future. EneCoat Technologies Co. was founded in 2018 by Atsushi Wakamiya and Naoya Kato, with Naoya Kato serving as the CEO since then.
3
| Holding Company | Semiconductors | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Atsushi Wakamiya via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Kyoto University | College/University | Undergraduate Degree | |
Kyoto University Innovation Capital Co., Ltd.
![]() Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Investment Managers | Private Equity Investor | |
Luxonus Co., Ltd.
![]() Luxonus Co., Ltd. Electronics/AppliancesConsumer Durables Luxonus Co., Ltd. manufactures photo acoustic imaging products. The company is based in Kawasaki, Japan. The Japanese company was founded by Sadakazu Aiso. | Electronics/Appliances | Director/Board Member | |
Rege Nephro Co. Ltd.
![]() Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
Japan | 5 |
Sectoral
Consumer Services | 2 |
Finance | 2 |
Consumer Durables | 2 |
Commercial Services | 2 |
Operational
Director/Board Member | 5 |
Private Equity Investor | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Undergraduate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Osami Kono | 4 |
Naoya Kato | 2 |
Hiroaki Tanaka | 1 |
- Stock Market
- Insiders
- Atsushi Wakamiya
- Company connections